ameloblastoma
Information
- Disease name
- ameloblastoma
- Disease ID
- DOID:0050894
- Description
- "A cell type benign neoplasm that has_material_basis_in odontogenic epithelium." [url:http\://en.wikipedia.org/wiki/Ameloblastoma]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02367859 | Completed | Phase 2 | Dabrafenib and Trametinib in Treating Patients With BRAF Mutated Ameloblastoma | July 17, 2017 | June 26, 2019 |
| NCT06264778 | Not yet recruiting | Phase 3 | Exploration of Fenestration Decompression Combined With Dalafenib in the Treatment of BRAF Mutant Ameloblastoma | March 1, 2024 | December 31, 2025 |
- Disase is a (Disease Ontology)
- DOID:0060084
- Cross Reference ID (Disease Ontology)
- GARD:5747
- Cross Reference ID (Disease Ontology)
- ICDO:9310/0
- Cross Reference ID (Disease Ontology)
- MESH:D000564
- OrphaNumber from OrphaNet (Orphanet)
- 314419
- MeSH unique ID (MeSH (Medical Subject Headings))
- D000564